Medical devices company Biocomposites has acquired a minority stake in UK-based Renovos Biologics, for an undisclosed sum.
Renovos has developed a synthetic, biodegradable nanoclay carrier called RENOVITE, which intends to place several pharmaceutical drugs and biologics at the treatment site.
A 23-gauge cannula is utilised for injecting this carrier to support minimally invasive procedures. It will transform into a stiff gel after it gets in contact with physiological fluids such as blood serum.
